Department of Hematology and Oncology, Konan Kosei Hospital, 137 Omatsubara, Takaya-cho, Konan, Aichi, 483-8704, Japan.
Int J Hematol. 2019 Jun;109(6):700-710. doi: 10.1007/s12185-019-02643-9. Epub 2019 Apr 10.
Cryptogenic organizing pneumonia (COP) after allogeneic hematopoietic stem cell transplantation (HSCT) is characterized by frequent recurrence. Few studies have examined onset and recurrence patterns of COP after HSCT. We investigated the clinical features of COP after HSCT in a single-center retrospective study including 165 consecutive patients who underwent allogeneic HSCT. Eighteen patients (11%) developed COP after HSCT. Hypoxemia and pleural effusion at the onset of COP were significantly associated with umbilical cord blood transplantation (P = 0.002 and P = 0.002, respectively). Recurrence of COP was observed in six patients and significantly associated with the presence of chronic graft-versus-host disease (cGVHD; P = 0.013) and stem cell sources other than umbilical cord blood (P = 0.038). Four patients with COP died of pulmonary failure after recurrence of COP. No patients who underwent umbilical cord blood transplantation experienced recurrence of COP. These findings suggest that the clinical features at the onset of COP may depend on stem cell sources. Moreover, both stem cell source and the absence or presence of cGVHD may affect COP recurrence, indicating the need to develop treatment strategies against COP according to stem cell source and risk of cGVHD.
异基因造血干细胞移植(HSCT)后发生的隐源性机化性肺炎(COP)的特点是频繁复发。很少有研究探讨 HSCT 后 COP 的发病和复发模式。我们通过一项单中心回顾性研究,调查了 165 例连续接受异基因 HSCT 的患者发生 COP 的临床特征。18 例(11%)患者在 HSCT 后发生 COP。COP 发病时的低氧血症和胸腔积液与脐带血移植显著相关(P=0.002 和 P=0.002)。6 例患者 COP 复发,与慢性移植物抗宿主病(cGVHD;P=0.013)和除脐带血以外的干细胞来源显著相关(P=0.038)。4 例 COP 患者因 COP 复发后出现肺衰竭而死亡。接受脐带血移植的患者无一例发生 COP 复发。这些发现表明,COP 发病时的临床特征可能取决于干细胞来源。此外,干细胞来源和 cGVHD 的有无都可能影响 COP 的复发,这表明需要根据干细胞来源和 cGVHD 的风险制定针对 COP 的治疗策略。